Hepatocellular Carcinoma Update - 30 nov 2021
Welcome & Introduction
Epidemiology and diagnosis of HCC
Screening and Surveillance of HCC
Current Treatment and Challenges in HCC MX
Role of Tecentriq (Atezolizumab) + Avastin (Bevacizumab) As 1L in Unresectable HCC
Panel Discussion - Managing patients with Atezolizumab Bevacizumab combination in unresectable HCC